Leukemia drug shows early promise for treating Parkinson's disease and dementia

(IOS Press) Parkinson's disease is the second most common neurodegenerative disorder that causes a range of motor and non-motor symptoms. During the course of the disease, dopamine-producing neurons are lost and bundles of proteins known as Lewy bodies form in the brain. A study reported in the Journal of Parkinson's Disease provided molecular evidence that the FDA-approved leukemia drug nilotinib may restore brain dopamine and reduce toxic proteins associated with LB formation in PD and dementia patients.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news